A Nashville, GA man has filed a short form complaint, which is part of the ongoing testosterone replacement therapy multidistrict litigation. George Lantis began taking Axiron in 2010 and used it until May 25, 2013. He claims testosterone replacement therapy caused him to suffer multiple serious and life-threatening blood clots.... Read more »

The Judicial Panel on Multidistrict Litigation (JPML) is a panel of federal judges that is authorized to determine whether civil actions pending in district courts should be moved to one federal court for consolidated pretrial proceedings. This centralization of cases is meant to help conserve judicial resources, reduce chance of duplicative... Read more »

A new testosterone therapy lawsuit has been filed by a Georgia couple over the heart attack suffered by the husband while he was taking Axiron, a testosterone replacement treatment produced by Eli Lilly. The complaint was filed by plaintiffs David T. Bowden and Judy Bowden of Polk County, GA on March... Read more »

An Axiron lawsuit has been filed over a heart attack death that plaintiffs contend was caused by testosterone replacement therapy. The complaint, filed on March 17 in the U.S. District Court for the Northern District of Illinois, Eastern Division, names Janice Ollenburger, individually and on behalf of Jerry Ollenburger, the... Read more »

Heart disease is one of the leading killers of both men and women in the United States, and experts across several medical fields have spent entire careers studying the direct or indirect causes of this destructive and chronic illness. In a recent study conducted by leading endocrinologists, researchers have uncovered... Read more »

On March 3, the U.S. Food and Drug Administration issued a warning on the testosterone heart attack risk for males using supplements to combat low levels of testosterone caused by aging. The FDA has required a labeling change to inform patients and the medical community of the possible increased risk... Read more »

For aging men, testosterone replacement therapy can help combat some of the physiological symptoms of decreasing testosterone levels – a condition known as “Low-T.” However, much like female hormone replacement therapy, Low-T treatments have come under increasing scrutiny for potential side effects and unexpected life-threatening ailments in patients receiving therapy... Read more »

Testosterone replacement therapy has been touted as the key to male vitality, enhanced libido and physical performance. After all, this powerful male hormone helps guys maintain muscle mass, sperm production and the all-important sex drive. Some four percent of men in their 60’s are taking testosterone supplements, according to a... Read more »

Recent studies have provided conflicting and controversial results regarding testosterone drug risk to patients undergoing testosterone replacement therapy. However, a new report titled “Testosterone Therapy and Risk of Myocardial Infarction: A Pharmacoepidemiologic Study” published on January 13, found statistically significant results. Researchers Mahyar Etminan, Sean C. Skeldon, Sheldon Larry Goldenberg,... Read more »

U.S. District Judge Matthew Kennelly has prescribed a case management plan and process for preparing bellwether trials in testosterone injury lawsuits not involving AbbVie’s AndroGel product, but rather the various testosterone treatments marketed and sold by several other manufacturers. Judge Kennelly’s order further clarifies a specific area of distinction among... Read more »